Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 2
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07539974Not ApplicableNot Yet Recruiting

Effect of Inspiratory Muscle Training on Diaphragm Function in COPD Patients

Role: collaborator

NCT07183384Phase 1Recruiting

MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction

Role: collaborator

NCT07034937Not ApplicableNot Yet Recruiting

Aerobic and Resistance Training in Post-CABG Patients

Role: collaborator

NCT05132972Phase 2Unknown

Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients

Role: collaborator

All 4 trials loaded